Therefore, this study involves the identification of various overexpressed protein members of the S100 protein family, including S100-A4, S100-A6, S100-A8, S100-A9, and S100-A11, to develop a successful multiepitope-based vaccine against pancreatic cancer. Here, S100A4 is linked to pancreatic neoplasm.